Introduction {#sec1}
============

Crystal engineering has played a major role in understanding the intermolecular interactions in the self-assembly of molecules and invoked it to generate new supramolecular assemblies without forming or breaking covalent bonds.^[@ref1]−[@ref3]^ In the rational design of the supramolecular structure, various noncovalent interactions such as hydrogen bonds,^[@ref4]−[@ref13]^ halogen bonds,^[@ref14]−[@ref24]^ van der Waals interactions, and π--π interactions^[@ref25],[@ref26]^ play a vital role. In particular, these noncovalent interactions have been extensively used in solid-state chemistry to assemble supramolecular building blocks into well-defined crystal structures. Hydrogen bonds are the unique tool in molecular recognition and play a master key role in the packing of crystal structures.^[@ref27]−[@ref31]^ Halogen bonds^[@ref32]−[@ref34]^ have attracted significant attention from the scientific community in recent years because of their vital role in crystal packing. In the last decade, Resnati and Metrangolo et al. have used halogen bonds extensively for studying the crystal packing of iodoperflurocarbon molecules with aliphatic amines.^[@ref35]−[@ref39]^ Jennifer and Muthiah designed and synthesized the cocrystals/salts of nitrogenous bases and thiophene carboxylic acid through a combination of hydrogen and halogen bonds.^[@ref40]^ Saha et al. studied the halogen bond interactions in iodopyridine derivatives.^[@ref41]^ Priimagi et al. reported the importance of halogen bonds in designing the functional materials in the fields of biomimetics, optics/photonics, functional surfaces, and photoswitchable supramolecules.^[@ref42]^ Anion-sensing property of receptors composed of halogen bond donor groups has been studied by Chudzinski et al.^[@ref43]^ Further, applications in the fields of liquid crystals, nanomaterials, polymer chemistry, inorganic chemistry, medicinal chemistry, and biochemistry have been achieved using halogen bond interactions.^[@ref44]^

Halogen bonds are not well-defined as hydrogen bonds, although they have strength, directionality, and specificity similar to those of hydrogen bonds.^[@ref45],[@ref46]^ In general, halogen bonds are defined as a noncovalent interaction between the halogen atom and electron donors such as N, O, and S, similar to hydrogen bonds. The theoretical and experimental studies on halogen bonds revealed that there is an anisotropic distribution of electron clouds along the covalently bonded halogen atom.^[@ref47]−[@ref50]^ As a result, a localized positive potential region is formed at the surface of the halogen atom, known as a σ hole.^[@ref51]^ The atoms having a nucleophilic character approach the halogen atom toward the σ hole and facilitate the formation of halogen bonds. Therefore, halogen bonds can be considered as the attractive interaction between the positive electrostatic potential region of a halogen atom and a negative site (halogen or electronegative atoms). This was well-explained by Politzer et al. in 2014 based on the computational methods.^[@ref52]^ However, in late 1980s, Desiraju and Parthasarathy demonstrated that because of the anisotropically segregated region of complementary electrostatic potential, halogen--halogen interaction is possible in the halogen atom which exhibits both electrophilic and nucleophilic characters.^[@ref53]^ As a consequence of the nonspherical atomic charge distribution among halogen atoms, the interhalogen bond (especially Cl···Cl bond) occurs, which is systematically explained by Price et al.^[@ref54]^ Weak Cl···O interaction was coined in organic chemistry in the year 1950, and in recent years, it has been used extensively for building supramolecular assemblies in crystal engineering.^[@ref55]^

The importance of halogen bond interactions in the pharmaceutical industry is that we can exploit these interactions in the design of new pharmaceutical drug products with definable structural and biological properties. A significant number of new drug molecules in the clinical development are halogenated compounds.^[@ref56]^ The incorporation of the halogen atoms in the new drug molecules could lead to an increase in the permeability of the molecules, thereby increasing their oral bioavailability.^[@ref57]−[@ref59]^ A few cocrystals/salts are designed and synthesized based on the halogen bond interactions.^[@ref60]−[@ref62]^ The first example of a pharmaceutical cocrystal involving halogen bonds as a major interaction was reported by Baldrighi et al. in the year 2013, wherein an antimicrobial drug 3-iodo-2-propynyl-*N*-butylcarbamate (IPBC) has been chosen as the key molecule.^[@ref63]^ Better physicochemical properties such as powder flowability and thermal stability were obtained for the cocrystal compared to those of the parent IPBC.

2-Chloro-4-nitrobenzoic acid (2c4n) is a derivative of benzoic acid which contains one electrophilic substituent and one labile group. This compound and most of its isomers (namely, 5-chloro-4-nitrobenzoic acid) are used as antiviral agents^[@ref64]^ in the pharmaceutical field. They are useful in the treatment of HIV infection and boost the immune response in immune deficiency diseases.^[@ref65]^ In the last two decades, numerous cocrystals/salts of 2c4n have been reported. Ishida et al. synthesized a series of cocrystals and salts of 2c4n with N-containing heterocycles. These include (2c4n)~2~·(pyrazine),^[@ref66]^ (2c4n)·(2,4,6-trimethyl pyridine),^[@ref67]^ (2c4n)·(3-cyanopyridine),^[@ref68]^ (2c4n)·(1,2,3-benzotriazole),^[@ref69]^ (2c4n)·(4-benzoylpyridine),^[@ref70]^ and (2c4n)·(quinoline).^[@ref71]^ In all reported molecular assemblies, acid···pyridine heterosynthon was found to be the most robust synthon. 4-Amino pyridine,^[@ref72]^ imidazole,^[@ref73]^ isopropylideneisonicotinohydrazide,^[@ref74]^ and 3,5-lutidine^[@ref75]^ were known to form salts with 2c4n using charge-assisted acid···pyridine hydrogen bonds. Lemmerer et al. synthesized a series of nine cocrystals/salts of 2c4n with various pyridine derivatives such as 2-bromopyridine, 3-amino-2-bromopyridine, 3-amino-2-chloropyridine, 2-amino-5-nitropyridine, 2-amino-3-bromopyridine, 2-chloro-3-hydroxypyridine, 2-amino-5-bromopyridine, 2,6-dimethylpyridine, and 2-amino-5-chloropyridine.^[@ref76]^ Further, solvates and polymorphic phase transformation of 2c4n were reported by Aitipamula et al. in the year 2011.^[@ref77]^

The interaction of carboxylic acid with pyridine nitrogen includes conventional and nonconventional hydrogen bonds and has been extensively studied in the design of various supramolecular nanostructures such as rosettes, rods, layers, tapes, sheets, ribbons, and sphere aggregates.^[@ref78]−[@ref80]^ Although numerous reports on cocrystals/salts of 2c4n are reported, the presence of weak secondary interactions, especially the presence of halogen bonds, and their importance in crystal packing were not illustrated much in the literature. Further, reports on the salt formation in the presence of other competing functionalities (carboxylic acid) are fewer in the literature. Hence, it is interesting to explore synthon formation when diverse functional groups are present that compete for synthon formation. Studies pertaining to the product formation in the presence of competitive functional groups such as amine (−NH~2~) are relatively sparse. Hence, heterocyclic amines have been chosen as well for studying the salt formation.

In this regard, an attempt was made to synthesize the molecular salts of 2c4n with various benzoic acid and pyridyl derivatives based on the pK~a~ values of 2c4n and the salt formers. The salt formers used are 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 2-aminothiazole, 2-aminobenzimidazole, 2-aminopyrimidine, 2-aminopyridine, and 3-aminopyridine ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Further, the present work aims to study and understand the nature of weak secondary interactions involved in the molecular salts, especially halogen bonds, and compare these nonbonded interactions with the reported salts/cocrystals of 2c4n to infer the presence of halogen bonds in these supramolecular architectures.

![Chemical Diagrams of 2c4n, 2-Aminobenzoic Acid (a), 3-Aminobenzoic Acid (b), 4-Aminobenzoic Acid (c), 2-Aminothiazole (d), 2-Aminobenzimidazole (e), 2-Aminopyrimidine (f), 2-Aminopyridine (g), and 3-Aminopyridine (h)](ao-2017-008784_0030){#sch1}

Results and Discussion {#sec2}
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Crystal Structure of Molecular Salts {#sec2-1}
------------------------------------

### 2c4n.a {#sec2-1-1}

The asymmetric unit in the molecular salt contains one molecule each of 2c4n and 2-aminobenzoic acid which was crystallized in a triclinic crystal system with the space group *P*1̅. The proton transfer from a carboxylic acid of 2c4n to 2-aminobenzoic acid was observed with a N--H···O bond distance of 2.734 Å (∠164.40°) ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}a). Two neighboring supramolecular units are interconnected through a N--H···O hydrogen bond (2.756 Å) between the amine group and the carboxylate of 2c4n, resulting in a cyclic tetrameric unit with an R~4~^2^ (8) graph set ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}b). This tetrameric unit further self-assembled through a complementary bifurcated N--H···O hydrogen bond (2.987 Å) and an −O--H···O hydrogen bond (2.521 Å) between the acid group of 2-aminobenzoic acid and the carboxylate of 2c4n, resulting in a linear one-dimensional (1D) tape ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}). The 1D structure is further converted to three-dimensional (3D) by utilizing a weak C--H···O hydrogen bond (3.239 Å) between aromatic C--H of 2c4n and O of the carboxylate of 2-aminobenzoic acid ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}). The crystallographic data and the hydrogen bond parameters are displayed in [Tables [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} and [2](#tbl2){ref-type="other"}.

![Asymmetric unit (a) and the tetrameric unit (b) of salt 2c4n.a.](ao-2017-008784_0001){#fig1}

![One-dimensional representation of the 2c4n.a salt.](ao-2017-008784_0012){#fig2}

![Three-dimensional representation of the 2c4n.a salt stabilized by a C--H···O hydrogen bond.](ao-2017-008784_0023){#fig3}

###### Crystallographic Data and the Refinement Parameters of the 2c4n Salts

  ----------------------- ---------------------- -------------------------- ---------------------- ---------------------- ---------------------- --------------------- ---------------------- ----------------------
  structure details       2c4n.a                 2c4n.b                     2c4n.c                 2c4n.d                 2c4n.e                 2c4n.f                2c4n.g                 2c4n.h
  CCDC number             961164                 961165                     961166                 961167                 961168                 1023271               961169                 992132
  formula                 C~14~H~12~ClN~2~O~6~   C~28~H~24~Cl~2~N~4~O~13~   C~14~H~12~ClN~2~O~6~   C~10~H~8~ClN~3~O~4~S   C~14~H~11~ClN~4~O~4~   C~11~H~9~ClN~4~O~4~   C~12~H~10~ClN~3~O~4~   C~12~H~10~ClN~3~O~4~
  *M*~r~                  338.70                 695.42                     338.70                 301.71                 334.72                 296.67                295.68                 295.68
  crystal system          triclinic              triclinic                  orthorhombic           triclinic              monoclinic             triclinic             triclinic              triclinic
  space group             *P*1̅                   *P*1̅                       *Pbca*                 *P*1̅                   *P*2~1~/*c*            *P*1̅                  *P*1̅                   *P*1̅
  *a*/Å                   8.1717(14)             10.856(3)                  7.2428(3)              7.0003(11)             11.7902(5)             6.7950(5)             5.7224(4)              5.9445(3)
  *b*/Å                   8.2522(14)             11.154(3)                  13.0520(6)             8.2219(19)             11.3110(5)             7.4766(5)             10.5903(7)             10.7390(5)
  *c*/Å                   10.856(18)             14.213(3)                  29.5375(13)            10.551(17)             12.3892(6)             13.7306(9)            11.2992(7)             10.9139(5)
  α/deg                   79.563(2)              106.325(3)                 90.00                  85.243(3)              90.00                  77.211(4)             95.938(10)             98.910(2)
  β/deg                   89.113(2)              104.731(3)                 90.00                  78.471(2)              109.790(10)            88.200(4)             103.751(10)            95.465(2)
  γ/deg                   83.600(2)              106.209(3)                 90.00                  79.703(2)              90.00                  69.323(4)             94.7420(10)            105.836(2)
  volume/Å^3^             715.5(2)               1479.1(6)                  2792.3(2)              584.77(19)             1554.63(12)            635.6(8)              657.47(8)              655.22(5)
  *Z*                     2                      2                          8                      2                      4                      2                     2                      2
  density \[g/cm^3^\]     1.577                  1.562                      1.611                  1.714                  1.430                  1.5                   1.494                  1.499
  μ (Mo Kα) \[mm^--1^\]   0.302                  0.297                      0.309                  0.519                  0.271                  0.320                 0.308                  0.309
  *T*/K                   296(2)                 296(2)                     293(2)                 296(2)                 296(2)                 296(2)                296 (2)                296 (2)
  reflections collected   2773                   5795                       3236                   2349                   3181                   2396                  2567                   2591
  unique reflections      2227                   4932                       2824                   2164                   2440                   2117                  2184                   2328
  parameter refined       252                    520                        208                    176                    224                    213                   193                    193
  *R*~1~ (*I* \> 2σ)      0.0468                 0.0438                     0.0449                 0.0265                 0.0495                 0.0726                0.0319                 0.0326
  w*R*~2~ (*I* \< 2σ)     0.1341                 0.1510                     0.1616                 0.0659                 0.1360                 0.2368                0.0878                 0.1155
  GOF                     0.922                  1.149                      1.354                  1.263                  1.525                  1.447                 0.625                  0.951
  ----------------------- ---------------------- -------------------------- ---------------------- ---------------------- ---------------------- --------------------- ---------------------- ----------------------

###### Geometrical Parameters of the Intermolecular Interactions in the Synthesized Molecular Salts of 2c4n

  salt     D--H···A[a](#t2fn1){ref-type="table-fn"}   H···A (Å)   D···A (Å)   ∠D--H···A (deg)   symmetry code
  -------- ------------------------------------------ ----------- ----------- ----------------- -----------------------------------
  2c4n.a   O6--H12···O1                               1.59        2.521       167               *x* -- 1, *y*, *z*
           N1--H10···O2                               1.85        2.756       156               --*x* + 1, --*y* + 1, --*z* + 1
           N1--H8···O3                                2.61        3.062       115               --*x*, --*y* + 2, --*z* + 1
           N1--H9···O2                                1.81        2.734       164               *x*, *y*, *z*
           N1--H8···O5                                1.92        2.659       144               *x*, *y*, *z*
  2c4n.b   O13--H24···O9                              2.26        2.973       151               *x*, *y*, *z*
           O12--H21···O1                              1.71        2.581       175               *x* + 1, *y*, *z* -- 1
           N4--H19···O2                               1.74        2.658       158               --*x* + 1, --*y* + 2, --*z* + 2
           N4--H22···O7                               2.60        3.029       110               --*x* + 1, --*y* + 2, --*z* + 1
           N4--H20···O6                               1.89        2.787       167               --*x* + 1, --*y* + 2, --*z* + 1
           O5--H1···O8                                1.78        2.612       163               *x*, *y*, *z*
           N2--H13···O13                              1.93        2.775       177               *x* -- 1, *y*, *z* + 1
           N2--H12···Cl1                              2.87        3.338       111               --*x*, --*y* + 1, --*z* + 1
           N2--H12···O8                               1.74        2.677       167               --*x*, --*y* + 1, --*z* + 1
  2c4n.c   N2--H10···O6                               1.92        2.828       171.0             *x*, *y*, *z*
           N2--H9···O5                                2.62        3.229       124.7             *x* -- 1/2, --*y* + 1/2, −*z*
           N2--H9···O6                                1.91        2.825       178.8             *x* -- 1/2, --*y* + 1/2, −*z*
           N2--H8···O5                                1.83        2.788       171.0             --*x* + 5/2, *y* -- 1/2, *z*
           O1--H11···O2                               1.95        2.723       160.7             *x* -- 1/2, *y*, --*z* + 1/2
  2c4n.d   N2--H6···O2                                2.014       2.846       162.5             *x* -- 1, *y* + 1, *z* -- 1
           N3--H8···O1                                1.69        2.634       174               *x* -- 1, *y* + 1, *z* -- 1
           N2--H7···O2                                2.174       2.892       140.91            --*x* + 1, −*y*, --*z* + 1
           N2--H7···O3                                2.543       3.143       127.68            *x* -- 1, *y*, *z*
  2c4n.e   N4--H11···O2                               1.92        2.827       170               --*x* + 2, −*y*, --*z* + 1
           N4--H10···O1                               2.09        2.859       156               --*x* + 2, *y* + 1/2, --*z* + 1/2
           N2--H8···O1                                2.60        3.298       130               --*x* + 2, *y* + 1/2, --*z* + 1/2
           N2--H8···O2                                1.80        2.759       173               --*x* + 2, *y* + 1/2, --*z* + 1/2
           N3--H9···O1                                1.89        2.70        163               *x*, *y*, *z*
  2c4n.f   N4--H7···N2                                2.13        3.036       174               --*x* + 1, --*y* + 1, --*z* + 1
           N3--H9···O2                                1.69        2.602       166               *x*, *y*, *z* -- 1
           N4--H8···O1                                1.98        2.823       166               *x*, *y*, *z* -- 1
  2c4n.g   C12--H7···O4                               2.314       3.229       167.98            --*x*, --*y* + 1, −*z*
           N3--H6···O4                                1.862       2.743       169.81            *x* -- 1, *y*, *z*
           N2--H4···O3                                1.924       2.804       178.01            *x* -- 1, *y*, *z*
           N2--H5···O3                                2.101       2.823       141.77            --*x* + 1, --*y* + 1, --*z* + 1
  2c4n.h   C12--H4···O2                               2.439       3.310       156.02            --*x*, --*y* + 1, −*z*
           C9--H2···O4                                2.492       3.239       137.47            --*x* + 2, --*y* + 1, --*z* + 1
           N1--H5···O2                                1.725       2.615       171.18            *x*, *y*, *z*
           N2--H6···O1                                2.174       2.935       163.38            --*x*, --*y* + 1, −*z*
           N2--H7···O1                                2.127       2.873       152.08            *x* + 1, *y* + 1, *z*

D: donor and A: acceptor.

### 2c4n.b {#sec2-1-2}

Salt 2c4n.b is crystallized in a triclinic crystal system with the *P*1̅ space group, and the asymmetric unit contains two ion pairs of 2c4n and 3-aminobenzoic acid along with one molecule of water ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). In the first instance, one molecule of 3-aminobenzoic acid interacted with one molecule each of 2c4n and 3-aminobenzoic acid through a −N--H···O hydrogen bond (3.029 and 2.787 Å, respectively) and a C--H···O hydrogen bond (3.165 Å); second, a 3-aminobenzoic acid molecule involved in a hydrogen bond with a water molecule with a −N--H···O bond distance of 2.776 Å. The water molecule further forms a hydrogen bond with the oxygen of 4-nitro group of 2c4n with an O--H···O bond distance of 2.973 Å. These molecular units further self-assembled through strong N--H···O and weak C--H···Cl and C--H···O hydrogen bonds, resulting in a two-dimensional (2D) network of the 2c4n.b salt ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). The unit repeats to form a 3D network which is stabilized by the π--π interaction between 2c4n and 3-aminobenzoic acid with a centroid--centroid distance of 3.636 Å ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}).

![Asymmetric unit in the molecular salt of 2c4n.b.](ao-2017-008784_0024){#fig4}

![Two-dimensional network-like structure of the 2c4n.b salt.](ao-2017-008784_0025){#fig5}

![Three-dimensional representation of the 2c4n.b salt stabilized by the π--π interaction.](ao-2017-008784_0026){#fig6}

### 2c4n.c {#sec2-1-3}

This molecular salt is crystallized in an orthorhombic crystal system with the space group *Pbca*, and the asymmetric unit contains one molecule each of 2c4n and 4-aminobenzoic acid ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}a). The primary synthon was found to be N^+^--H···O^--^ heterosynthon with a distance of 2.828 Å. These supramolecular units are connected to the neighboring units through three different complementary N--H···O hydrogen bonds (2.788, 2.825, and 3.229 Å), resulting in the cyclic tetrameric unit ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}b). These units further repeat to form a 1D sheet ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}) via a C--H···O hydrogen bond (between two 2c4n molecules) and an O--H···O hydrogen bond (between two 4-aminobenzoic acid molecules). It is further converted to a 3D ladder kind of arrangement that is stabilized by the π--π interaction between 2c4n and 4-aminobenzoic acid with a centroid--centroid distance of 3.615 Å ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}).

![Asymmetric unit (a) and tetrameric unit (b) of the 2c4n.c salt.](ao-2017-008784_0027){#fig7}

![One-dimensional representation of the 2c4n.c salt.](ao-2017-008784_0028){#fig8}

![Three-dimensional representation of the 2c4n.c salt.](ao-2017-008784_0029){#fig9}

### 2c4n.d {#sec2-1-4}

The product is crystallized in a triclinic crystal system with the space group *P*1̅ with one molecule each of 2c4n and 2-aminothiazole in the asymmetric unit. The primary interaction is the N^+^--H (azole)···O^--^ (carboxylate) hydrogen bond (2.634 Å, ∠173.9°) and N--H···O hydrogen bond (2.846 Å, ∠162.45°) between 2c4n and 2-aminothiazole ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}a). Two neighboring supramolecular adducts are interconnected through a strong complementary N--H···O hydrogen bond (2.892 Å) and a weak Cl···S halogen bond (3.405 Å), resulting in a cyclic tetrameric unit with R~4~^2^ (8) ring motifs ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}b). The tetramers are interconnected to form a 1D and then a 2D chain along the *b* axis via Cl···S and Cl···O halogen bonds (3.405 and 3.102 Å, respectively) and a S···O chalcogen bond (3.016 Å) ([Figures [11](#fig11){ref-type="fig"}](#fig11){ref-type="fig"} and [12](#fig12){ref-type="fig"}). These further recur to form a 3D network that is stabilized by a C--H (azole)···O (carboxylate) hydrogen bond (3.339 Å).

![Asymmetric unit (a) and tetrameric unit (b) of the 2c4n.d salt.](ao-2017-008784_0002){#fig10}

![Linear 1D chain of the 2c4n.d salt.](ao-2017-008784_0003){#fig11}

![Two-dimensional chain of the 2c4n.d salt stabilized via a Cl···O halogen bond.](ao-2017-008784_0004){#fig12}

### 2c4n.e {#sec2-1-5}

2c4n.e is crystallized in a monoclinic crystal system with the space group *P*2~1~/*c*. The asymmetric unit contains one molecule each of 2c4n and the 2-aminobenzimidazolium ion ([Figure [13](#fig13){ref-type="fig"}](#fig13){ref-type="fig"}). The proton transfer was observed from 2c4n to the imidazole nitrogen of 2-aminobenzimidazole. Each of the carboxylate oxygen of 2c4n is involved in a hydrogen bond with the imidazole via N^+^--H (imidazole)···O^--^ (2.759 Å, ∠172.99°) and N--H (amine)···O^--^ hydrogen bonds (2.859 Å, ∠156.37°). The dimers are connected to each other through a N--H (imidazole)···O^--^ hydrogen bond (2.703 Å) and a Cl···O halogen bond (3.205 Å) on the other side that recurs to form a V-shaped network ([Figure [14](#fig14){ref-type="fig"}](#fig14){ref-type="fig"}). The overall crystal structure features weak secondary interactions such as a C--H···O hydrogen bond (3.532 Å) between two 2c4n molecules and a C--H···O hydrogen bond (3.410 Å) between aromatic C--H of 2-aminobenzimidazole and the nitro group of 2c4n ([Figure [15](#fig15){ref-type="fig"}](#fig15){ref-type="fig"}).

![Asymmetric unit of the 2c4n.e salt.](ao-2017-008784_0005){#fig13}

![V-shaped network-like structure of the 2c4n.e salt stabilized by a Cl···O halogen bond.](ao-2017-008784_0006){#fig14}

![Three-dimensional representation of the 2c4n.e salt.](ao-2017-008784_0007){#fig15}

### 2c4n.f {#sec2-1-6}

The product is crystallized in a triclinic crystal system with the space group *P*1̅, and the asymmetric unit comprised one molecule each of 2c4n anion and 2-amino pyrimidinium cation. The primary synthon in the crystal structure comprised N^+^--H (pyrimidine)···O^--^ (carboxylate of 2c4n) and N--H (amine of 2-aminopyrimidine)···O^--^ (carboxylate) hydrogen bonds with bond distances of 2.602 and 2.823 Å, respectively ([Figure [16](#fig16){ref-type="fig"}](#fig16){ref-type="fig"}). It is further interconnected to the neighboring unit via a complementary N--H···N hydrogen bond (3.036 Å) to form a heterodimer. These units repeat to form a 1D linear chain mediated by a C--H···O hydrogen bond between 2c4n molecules (3.355 Å) ([Figure [17](#fig17){ref-type="fig"}](#fig17){ref-type="fig"}). It is further converted to a 3D structure by utilizing a weak C--H···Cl hydrogen bond (3.695 Å) and a C--H···O hydrogen bond between the oxygen of the nitro group of 2c4n and C--H of the 2-aminopyrimidine molecule. The overall crystal structure also features the π--π interaction between 2-aminopyridine molecules with a centroid-to-centroid bond distance of 3.409 Å ([Figure [18](#fig18){ref-type="fig"}](#fig18){ref-type="fig"}).

![Asymmetric unit of the 2c4n.f salt.](ao-2017-008784_0008){#fig16}

![One-dimensional representation of the 2c4n.f salt mediated by a C--H···O hydrogen bond.](ao-2017-008784_0009){#fig17}

![Three-dimensional representation of the 2c4n.f salt.](ao-2017-008784_0010){#fig18}

### 2c4n.g {#sec2-1-7}

A 1:1 molecular salt of 2c4n and 2-aminopyridine was obtained and is crystallized in the triclinic space group *P*1̅. In the crystal structure, the asymmetric unit contains two crystallographically independent molecules, each of 2c4n and 2-aminopyridine. The primary synthon is a two-point supramolecular synthon which is assembled through a charge-assisted complementary hydrogen bond between carboxylic acid and aminopyridine moiety, resulting in a dimeric unit (2.743 Å) ([Figure [19](#fig19){ref-type="fig"}](#fig19){ref-type="fig"}). Adjacent dimers are further linked through a self-complementary N--H···O (2.823 Å) hydrogen bond to form cyclic heterotetramers. These heterotetramers are mediated by a secondary C--H···O (3.229 Å) interaction to form a supramolecular 1D column ([Figure [20](#fig20){ref-type="fig"}](#fig20){ref-type="fig"}). The 1D column is interconnected to the neighboring column through a secondary C--H···O interaction involving C--H of the pyridine ring and the oxygen of the nitro group of 2c4n to form a 2D supramolecular sheetlike structure ([Figure [21](#fig21){ref-type="fig"}](#fig21){ref-type="fig"}). The dimensionality of the supramolecular structure of 2c4n.g increased by a weak Cl···Cl interaction. The supramolecular sheets are interconnected to the neighboring ones in a vertical plane through a Cl···Cl halogen bond (3.481 Å) ([Figure [22](#fig22){ref-type="fig"}](#fig22){ref-type="fig"}).

![Asymmetric unit in salt 2c4n.g.](ao-2017-008784_0011){#fig19}

![One-dimensional column stabilized by a C--H···O interaction in salt 2c4n.g.](ao-2017-008784_0013){#fig20}

![Two-dimensional supramolecular sheet stabilized by a C--H···O interaction in salt 2c4n.g.](ao-2017-008784_0014){#fig21}

![Cl···Cl interaction in the crystal structure of salt 2c4n.g.](ao-2017-008784_0015){#fig22}

### 2c4n.h {#sec2-1-8}

2c4n and 3-aminopyridine afforded a crystalline salt in a 1:1 ratio which is crystallized in a triclinic crystal system with the space group *P*1̅. The asymmetric unit of the salt contains one 3-aminopyridine cation and one 2c4n anion. The primary synthon is a single-point supramolecular synthon in which a proton from the carboxylic group is transferred to the pyridine nitrogen atom with a N--H···O bond distance of 2.615 Å ([Figure [23](#fig23){ref-type="fig"}](#fig23){ref-type="fig"}). The proton transfer from the acid to the N atom of pyridine is reflected by an increase in the C--N--C bond angle (123.44°) compared to that of the neutral molecule (117.7°--118.5°). The two neighboring ion pairs are linked through complementary N--H···O (2.935 Å) hydrogen bonds to form a cyclic heterotetramer. These heterotetramers are further combined through N--H···O hydrogen bonds (2.873 Å) to form a 1D column ([Figure [24](#fig24){ref-type="fig"}](#fig24){ref-type="fig"}). These supramolecular 1D columns are interconnected to the neighboring column through a secondary C--H···O hydrogen bond (3.239 Å) which results in a 2D supramolecular sheet ([Figure [25](#fig25){ref-type="fig"}](#fig25){ref-type="fig"}). Similar to salt 2c4n.g, the dimensionality of the crystal structure of 2c4n.h is increased by a weak Cl···Cl interaction. The supramolecular columns are interconnected to the neighboring columns through a chlorine--chlorine interaction with a Cl···Cl distance of 3.305 Å ([Figure [26](#fig26){ref-type="fig"}](#fig26){ref-type="fig"}).

![Asymmetric unit in salt 2c4n.h.](ao-2017-008784_0016){#fig23}

![One-dimensional column held by a N--H···O hydrogen bond in salt 2c4n.h.](ao-2017-008784_0017){#fig24}

![Two-dimensional supramolecular sheet stabilized by a C--H···O interaction in salt 2c4n.h.](ao-2017-008784_0018){#fig25}

![Cl···Cl interaction in the crystal structure of salt 2c4n.h.](ao-2017-008784_0019){#fig26}

Role of Halogen Bonds in the Present Work and the Reported Salts/Cocrystals of 2c4n in Building a Supramolecular Network {#sec2-2}
------------------------------------------------------------------------------------------------------------------------

Among the 24 reported molecular adducts and 8 synthesized molecular salts of 2c4n, only 12 and 4 molecular salts/cocrystals exhibited halogen bonds in their crystal structures. Molecular structures of the reported salts/coformers of 2c4n are shown in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}. Conformational changes in the carboxylate group were observed in the synthesized molecular salts and in the reported molecular adducts of 2c4n as well. Synthesized molecular salts such as 2c4n.d, 2c4n.e, 2c4n.g, and 2c4n.h exhibited halogen bonds in their crystal structures, which along with hydrogen bonds are responsible for the overall crystal stability of the molecular salts. However, the crystal structures of the remaining salts were stabilized via C--H···Cl and C--H···O hydrogen bonds except for the 2c4n.a salt, where chlorine was not involved in the intermolecular bond formation. It is worth noticing that the synthesized as well as the reported molecular adducts showed a similar kind of conformational change for the adducts involving halogen bonds in their crystal structures, whereas the conformation was found to be slightly twisted in the rest of the salts to attain the stable forms ([Figure [27](#fig27){ref-type="fig"}](#fig27){ref-type="fig"}). Torsion angles of the synthesized molecular salts of 2c4n are listed in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00878/suppl_file/ao7b00878_si_001.pdf) (Table S1).

![Conformational plot of the crystal structure of 2c4n derived from the synthesized molecular salts (red: 2c4n.a, blue: 2c4n.b, orange: 2c4n.c, green: 2c4n.d, purple: 2c4n.e, magenta: 2c4n.f, gray: 2c4n.g, and yellow: 2c4n.h).](ao-2017-008784_0020){#fig27}

![Molecular Structures of the Salt Formers/Coformers Reported with 2c4n](ao-2017-008784_0031){#sch2}

Attempts have been made to systematically study the presence of halogen bonds in the 24 reported molecular adducts and 8 synthesized salts. Efforts were made to correlate the presence of halogen bonds in these crystal structures with the arrangement of molecules in the crystal lattice. Further, the effect of substituent groups in the counterion molecule was studied. It was observed that the molecular components interacted through a two-point primary supramolecular synthon rather than a single-point supramolecular synthon in the crystal structure ([Figure [28](#fig28){ref-type="fig"}](#fig28){ref-type="fig"}) were more likely to exhibit halogen bonds. However, there were exceptions where the molecular salt/cocrystal was found to be stabilized via a C--H···Cl hydrogen bond rather than a halogen bond. It was further understood that stronger intramolecular halogen bonds in 2c4n are more susceptible to form intermolecular halogen bonds ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Lommerse et al.^[@ref81]^ defined the parameter *R* to bring interacting halogen bond distances into a standardized scale, which is given bywhere *d* is the X--D distance and *r*~x~ and *r*~d~ are the standard van der Waals radii of the participating atoms. The parameter *R* for the molecular adducts that exhibited halogen bonds is listed in [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}.

![Two-point and single-point heterosynthon representation.](ao-2017-008784_0021){#fig28}

###### Intramolecular Halogen Bond Distances and the Observed Primary Synthon in the 2c4n Salts

  molecular salts of 2c4n              intramolecular Cl···O halogen bond distance (Å)   presence of halogen bonds   observed primary synthon
  ------------------------------------ ------------------------------------------------- --------------------------- --------------------------
  2c4n.a                               3.210                                             ×                           single point
  2c4n.b                               3.070 & 3.003                                     ×                           single point
  2c4n.c                               3.200                                             ×                           single point
  2c4n.d                               2.992                                             √                           two point
  2c4n.e                               3.038                                             √                           two point
  2c4n.f                               3.161                                             ×                           two point
  2c4n.g                               3.055                                             √                           two point
  2c4n.h                               3.141                                             √                           single point
  benzotriazole                        2.917                                             √                           single point
  2-amino-3-bromopyridine              ×                                                 √                           two point
  2-amino-5-bromopyridine              ×                                                 √                           two point
  2-amino-5-chloropyridine             ×                                                 √                           two point
  2-amino-5-nitropyridine              3.023                                             √                           single point
  2-bromopyridine                      ×                                                 √                           single point
  bipyridine^[@ref82]^                 3.011                                             √                           single point
  2-chloro-3-hydroxypyridine           ×                                                 √                           single point
  4-aminopyridine                      2.889                                             ×                           single point
  lutidine^[@ref83]^                   2.898                                             √                           single point
  morpholine^[@ref84]^                 ×                                                 ×                           single point
  nicotinamide^[@ref85]^               2.750                                             √                           single point
  quinoline                            3.031                                             √                           single point
  pyrazine                             3.004                                             ×                           single point
  2,6-dimethylpyridine                 ×                                                 ×                           single point
  2-bromo-3-aminopyridine              ×                                                 ×                           single point
  3-aminophenol^[@ref86]^              ×                                                 ×                           single point
  3-cyanopyridine                      3.063                                             ×                           single point
  2-chloro-3-aminopyridine             ×                                                 ×                           single point
  benzimidazole^[@ref87]^              ×                                                 ×                           single point
  imidazole                            3.250                                             ×                           single point
  isoniazid^[@ref88]^                  3.079                                             ×                           single point
  isopropylideneisonicotinohydrazide   2.910, 2.892                                      √                           single point
  4-benzoylpyridine                    ×                                                 ×                           single point

###### Relevant Halogen Bonds and Standardized Parameter *R* for the Molecular Salts[a](#t4fn1){ref-type="table-fn"}

  molecular adducts of 2c4n            *d*(Cl···Cl) Å, *d*(Br···Br)\* Å   *d*(Cl···O) Å, *d*(Br···O)\* Å   *d*(Cl···S) Å, *d*(Cl···Br)\* Å, *d*(Cl···N)^§^ Å   *R*
  ------------------------------------ ---------------------------------- -------------------------------- --------------------------------------------------- -------------
  2c4n.d                                                                  3.102                            3.405                                               0.95 & 0.96
  2c4n.e                                                                  3.205                                                                                0.98
  2c4n.g                               3.481                                                                                                                   0.99
  2c4n.h                               3.305                                                                                                                   0.94
  benzotriazole                                                           3.164                                                                                0.97
  2-amino-3-bromopyridine\*                                                                                3.527                                               0.98
  2-amino-5-bromopyridine\*                                               3.145                                                                                0.93
  2-amino-5-chloropyridine                                                3.143                                                                                0.96
  2-amino-5-nitropyridine                                                 3.108                                                                                0.95
  2-bromopyridne\*                     3.630                                                                                                                   0.98
  bipyridine                                                              3.117                                                                                0.95
  2-chloro-3-hydroxypyridine           3.388                                                                                                                   0.97
  lutidine                                                                3.120                                                                                0.95
  nicotinamide^§^                                                                                          3.077                                               0.93
  quinoline                                                               3.115                                                                                0.95
  isopropylideneisonicotinohydrazide                                      3.127, 3.180                                                                         0.96, 0.97

\* and § symbols were given to show the exact interaction distances (like Cl···Br and Cl···N).

From [Table [4](#tbl4){ref-type="other"}](#tbl4){ref-type="other"}, it is clear that quite strong Cl···O, Br···O, and Cl···N halogen bonds with *R* values of 0.94, 0.93, and 0.93 were formed in the molecular adducts of 2c4n with 3-aminopyridne, 2-amino-5-bromopyridine, and nicotinamide, respectively. A moderately strong halogen bond was observed in the cases of 2c4n.d, 2c4n.h, 2-amino-5-nitropyridne, bipyridine, lutidine, and quinoline adducts of 2c4n. In the remaining molecular adducts, only weaker halogen bond interactions were observed which is attributed to a higher *R* value.

Significance of the p*K*~a~ Value as a Tool to Predict Cocrystals or Salts {#sec2-3}
--------------------------------------------------------------------------

The prediction of formation of salts or cocrystals is one of the major challenges before crystal engineering.^[@ref89]^ Earlier literature suggested that the proton transfer from the acid to a nitrogen atom of the N-heterocyclic compound occurs based on the difference in the p*K*~a~ values of acid and the conjugate acid of the N-heterocyclic base. Proton transfer will occur when Δp*K*~a~ \> 3, whereas cocrystal will form for Δp*K*~a~ \< 3. There is an ambiguity in the region 0 \< Δp*K*~a~ \< 3, where the probability of formation of salts increases as the Δp*K*~a~ increases.^[@ref90]−[@ref94]^ However, in reality, the p*K*~a~ value of acids and bases is bound to vary based on the chosen solvent and other components associated with the reaction. As a result, it is difficult to predict the nature of the resultant compounds.

The Δp*K*~a~ values for various reported salt formers used with 2c4n are shown in [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}. In general, it is expected that cocrystal formation is predominant when Δp*K*~a~ \< 0 and salt formation is predominant when Δp*K*~a~ is greater than 3. A similar trend is observed in the reported molecular adducts of 2c4n. In most of the cases, salt formation is observed when the Δp*K*~a~ lies above 3 units. However, in few cases, cocrystal formation is observed if the Δp*K*~a~ value is close to 3 units, as shown in [Table [5](#tbl5){ref-type="other"}](#tbl5){ref-type="other"}. Cocrystal formation is found to be predominant when the Δp*K*~a~ lies below 0 units. Therefore, the region in between 0 and 3 (Δp*K*~a~) is considered as a salt--cocrystal continuum.^[@ref90]−[@ref94]^

###### Comparison of Δp*K*~a~ of Salts/Cocrystals of 2c4n with Different Coformers[a](#t5fn1){ref-type="table-fn"}

  active pharmaceutical ingredient/salt former   p*K*~a~ of the base   Δp*K*~a~   salt/cocrystal   Δ*D*~C--O~
  ---------------------------------------------- --------------------- ---------- ---------------- --------------
  2c4n (p*K*~a~: 1.96)                                                                              
  2-aminobenzoic acid                            4.95                  2.99       salt             0.006
  3-aminobenzoic acid                            5.10                  3.14       salt             0.034, 0.041
  4-aminobenzoic acid                            4.87                  2.91       salt             0.027
  2-aminothiazole                                5.5                   3.54       salt             0.013
  2-aminobenzimidazole                           7.51                  5.55       salt             0.003
  2-aminopyrimidine                              3.54                  1.58       salt             0.038
  2-aminopyridne                                 6.82                  4.86       salt             0.003
  3-aminopyridne                                 5.98                  4.02       salt             0.014
  benzotriazole                                  \<0                   --1.96     cocrystal        0.108
  2-amino-3-bromopyridine                        4.14                  2.18       salt             0.005
  2-amino-5-bromopyridine                        4.65                  2.69       salt             0.017
  2-amino-5-chloropyridine                       4.67                  2.71       salt             0.017
  2-amino-5-nitro pyridine                       2.78                  0.82       cocrystal        0.095
  2-bromopyridine                                0.79                  --1.17     cocrystal        0.133
  bipyridine                                     3.27                  1.31       cocrystal        0.086
  2-chloro-3-hydroxypyridine                     4.32                  2.36       cocrystal        0.101
  4-amino pyridine                               9.11                  7.15       salt             0.019
  lutidine                                       6.14                  4.18       salt             0.117
  morpholine                                     8.36                  6.4        salt             0.044
  nicotinamide                                   3.33                  1.37       cocrystal        0.073
  quinoline                                      4.85                  2.89       cocrystal        0.101
  pyrazine                                       0.65                  --1.31     cocrystal        0.127
  2,6-dimethylpyridine                           6.60                  4.64       salt             0.036
  2-bromo-3-aminopyridine                        1.72                  --0.24     cocrystal        0.103
  3-aminophenol                                  9.87                  7.91       salt             0.001
  3-cyanopyridine                                1.36                  --0.6      cocrystal        0.102
  2-chloro-3-aminopyridine                       2.42                  0.46       cocrystal        0.115
  benzimidazole                                  5.4                   3.44       salt             0.013
  imidazole                                      6.95                  4.99       salt             0.004
  isoniazid                                      3.35                  1.39       cocrystal        0.105
  4-benzoylpyridine                              4.2                   2.24       cocrystal        0.100

Δp*K*~a~ = p*K*~a1~ (conjugate acid of the base) -- p*K*~a2~ (acid); Δ*D*~C--O~ = *d*(carboxylate group) -- *d*(carboxyl group).

A plot of all cocrystals and salts including some of the compounds reported in the literature is shown in [Figure [29](#fig29){ref-type="fig"}](#fig29){ref-type="fig"}. The *x*-axis corresponds to Δp*K*~a~ \[p*K*~a~ (conjugate acid of the base) -- p*K*~a~ (acid)\] while the *y*-axis corresponds to the Δ*D* (the difference between the lengths of the two C--O bonds in a carboxyl group) bond length. The Δ*D* value for a cocrystal is found to be high; therefore, the top left corner of the scatter plot corresponds to cocrystal formation and the bottom right corner corresponds to salt formation. A similar kind of scattergram plot is reported in the literature as well.^[@ref95]^

![Plot of Δp*K*~a~ vs Δ*D*~C--O~ for 2c4n with different coformers.](ao-2017-008784_0022){#fig29}

Thermal Study {#sec2-4}
-------------

Differential scanning calorimetry (DSC) analysis was performed to study the thermal stability of the synthesized molecular salts. Salts with benzoic acid derivatives (2c4n.a, 2c4n.b, and 2c4n.c) melt in between/nearly equal to the melting temperatures of 2c4n and salt formers. No correlation of the melting point of these salts with the crystal density is observed. In 2c4n.b and 2c4n.c, phase transformation was observed which is possibly due to the existence of polymorphism in these salts. A higher melting temperature was observed for the pyridine derivative salt of 2c4n when compared to its respective starting materials. The melting points of 2c4n and the salts are shown in [Table [6](#tbl6){ref-type="other"}](#tbl6){ref-type="other"}. Because of the isostructurality of 2c4n.g and 2c4n.h, their densities and melting temperatures were found to be approximately similar. It is surprising that the melting temperature of 2c4n.e was found to be higher when compared to those of all other synthesized salts even though the crystal density was low, which indicates the high thermal stability of salt 2c4n.e. It is further observed that a higher melting temperature was observed for those salts that exhibited halogen bonds in their crystal structures. DSC thermogram is displayed in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00878/suppl_file/ao7b00878_si_001.pdf) Figure S1.

###### Melting Points of 2c4n and the Molecular Salts

  sl. no.   active pharmaceutical ingredient/salt   melting point (°C)   melting point of the salt (°C)   molecular adduct
  --------- --------------------------------------- -------------------- -------------------------------- ------------------
  1         2c4n                                    145--148                                               
  2         2-aminobenzoic acid (a)                 146--148             150.1                            salt
  3         3-aminobenzoic acid (b)                 176--180             155.93, 174.18                   salt
  4         4-aminobenzoic acid (c)                 187--189             160.1, 165.9                     salt
  5         2-aminothiazole (d)                     86--89               167.23                           salt
  6         2-aminobenzimidazole (e)                226--230             248.3                            salt
  7         2-aminopyrimidine (f)                   59--60               161.4                            salt
  8         2-aminopyridine (g)                     54--58               165.21                           salt
  9         3-aminopyridine (h)                     60--63               162.91                           salt

Fourier Transform Infrared Spectroscopy {#sec2-5}
---------------------------------------

Generally, IR spectroscopy is used to identify the functional group present in the molecule. It also gives information about the hydrogen bonds present in the molecule. Salt formation can be confirmed by observing changes in the carbonyl stretching frequency as the ionization causes a reduction in the carbonyl stretching frequency. On the basis of the changes in these stretching frequencies, we ascertained the formation of new solid forms. −C=O stretching frequency for 2c4n was observed at 1704 cm^--1^. In all molecular salts, ionization caused a large shift in the carbonyl stretching frequency for pyridyl derivative salts; however, in the case of benzoic acid derivative salts, a considerable shift in the stretching frequency was observed. The Fourier transform infrared (FT-IR) spectra and the stretching values are shown in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00878/suppl_file/ao7b00878_si_001.pdf) (Figures S10--S17 and Table S2).

Powder X-ray Diffraction Analysis {#sec2-6}
---------------------------------

Powder X-ray diffraction (PXRD) analysis is the prerequisite for the confirmation of formation of new molecular components. In the present study, PXRD analysis is carried out to confirm the bulk purity of the synthesized molecular salts. All synthesized molecular salts were found to be pure in the bulk. The PXRD pattern is shown in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00878/suppl_file/ao7b00878_si_001.pdf) (Figures S2--S9).

^1^H NMR Spectroscopy {#sec2-7}
---------------------

All synthesized molecular salts exhibited a 1:1 molecular stoichiometry in their asymmetric unit. The ^1^H NMR spectra and the spectral details are given in the [Supporting Information](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00878/suppl_file/ao7b00878_si_001.pdf) (Figures S18--S25).

Conclusions {#sec3}
===========

In summary, a series of eight molecular salts of 2c4n have been synthesized in view of studying the presence of halogen bonds in the molecular salts/cocrystals of 2c4n. Four synthesized molecular salts and 12 out of 24 reported molecular adducts of 2c4n were found to exhibit halogen bonds in their crystal structures. The synthesized molecular salts were characterized by various spectroscopic, thermal, and X-ray diffraction techniques. In all synthesized salts, proton transfer from the carboxylic acid group to the pyridyl nitrogen/amino group was observed. All synthesized salts were found to be anhydrous except for 2c4n.b, which is monohydrate. Conformational analysis of the synthesized and the reported molecular salts revealed that 2c4n exhibited two different conformations in the molecular adducts; a similar kind of conformation was observed for the salts exhibiting halogen bonds in their crystal structures. Two of the synthesized molecular salts were found to be isostructural as well (2c4n.g and 2c4n.h). In the synthesized and the reported molecular adducts of 2c4n, the acid···pyridine heterosynthon was found to be the robust. Detailed inspection of the reported and the synthesized molecular adducts of 2c4n revealed that two-point primary supramolecular synthon and stronger intramolecular Cl···O halogen bonds in the crystal structures are more prone to exhibit halogen bonds in their crystal structures. From the single-crystal X-ray diffraction (SC-XRD) study, it is strongly suggested that two-point heterosynthon is more likely to exhibit halogen bonds though the conformational change of the carboxylate group of 2c4n occurs. Halogen bonds played a major role in the crystal packing of these molecular adducts, based on the SC-XRD study.

Experimental Section {#sec4}
====================

Materials and Methods {#sec4-1}
---------------------

All chemicals were purchased from Sigma-Aldrich and used as such without any further purification. All solvents used were of analytical or chromatographic grade.

Synthesis of Molecular Salts {#sec4-2}
----------------------------

### 2c4n.a {#sec4-2-1}

A mixture of 2c4n (200 mg, 0.99 mmol) and 2-aminobenzoic acid (136 mg, 0.99 mmol) was taken in 5 mL of methanol, sonicated for complete dissolution, and then kept for crystallization at ambient temperature. Cream-colored columnar crystals were obtained in 2 days.

### 2c4n.b {#sec4-2-2}

A mixture of 2c4n (200 mg, 0.99 mmol) and 3-aminobenzoic acid (136 mg, 0.99 mmol) was taken in a 1:1 mixture of acetonitrile and methanol (4 mL) and sonicated for complete dissolution. It was then allowed for crystallization at room temperature. Block-shaped brown-colored crystals were obtained in 2 days.

### 2c4n.c {#sec4-2-3}

A mixture of 2c4n (200 mg, 0.99 mmol) and 4-aminobenzoic acid (136 mg, 0.99 mmol) was dissolved in a 5:2 mixture of acetonitrile and methanol (7 mL) by sonication. It was then allowed for slow evaporation at room temperature. Plate-shaped pink-colored crystals were obtained in 2 days.

### 2c4n.d {#sec4-2-4}

A mixture of 2c4n (200 mg, 0.99 mmol) and 2-aminothiazole (99.1 mg, 0.99 mmol) was dissolved in a 5:1 mixture of acetonitrile and dimethyl sulfoxide (DMSO) (6 mL) by sonication and then allowed for slow evaporation. Block-shaped brown-colored crystals were obtained in 4 days.

### 2c4n.e {#sec4-2-5}

A mixture of 2c4n (200 mg, 0.99 mmol) and 2-aminobenzimidazole (132.11 mg, 0.99 mmol) was dissolved in a 5:2 mixture of methanol and dimethylformamide (7 mL) by sonication and then allowed for slow evaporation. Transparent plate-shaped crystals were obtained in 3 days.

### 2c4n.f {#sec4-2-6}

A mixture of 2c4n (200 mg, 0.99 mmol) and 2-aminopyrimidine (94.37 mg, 0.99 mmol) was dissolved in a 7:1 mixture of methanol and 1,4-dioxane (8 mL) by sonication and then allowed for slow evaporation. Plate-shaped cream-colored crystals were obtained in 5 days.

### 2c4n.g {#sec4-2-7}

A 1:1 stoichiometric amount of 2c4n (200 mg, 0.99 mmol) and 2-aminopyridine (93.38 mg, 0.99 mmol) was mixed together, dissolved in 5 mL of methanol solvent by sonication, and then allowed for slow evaporation at room temperature. Plate-shaped pale yellow-colored crystals were obtained after 4 days.

### 2c4n.h {#sec4-2-8}

A 1:1 stoichiometric amount of 2c4n (200 mg, 0.99 mmol) and 3-aminopyridine (93.38 mg, 0.99 mmol) was mixed together, then dissolved in 6 mL of methanol solvent by sonication, and allowed for slow evaporation at room temperature. Block-shaped pale yellow-colored crystals were obtained after 4 days.

X-ray Crystallography {#sec4-3}
---------------------

X-ray crystal data were collected for the synthesized molecular salts at room temperature using a Bruker Smart Apex Duo single-crystal X-ray diffractometer with a dual system charge-coupled device detector. Monochromatic Mo Kα radiation (λ = 0.7103 Å) was used for the measurements. The data integration and reduction were carried out using SAINT-Plus software. An empirical absorption correction was applied to the collected reflections with SADABS. All structures were solved by direct methods using SHELXS97 and SHELXL2007/2014, and refinement was carried out by the full-matrix least-squares technique. Anisotropic displacement parameters were calculated for all nonhydrogen atoms. H atoms attached to the N atoms were located in a difference Fourier density map and refined isotropically. The program PLATON^[@ref96]^ was used to generate the hydrogen bond table, whereas MERCURY was used for all graphical representations of the results.

^1^H NMR Spectroscopy {#sec4-4}
---------------------

^1^H NMR spectrum is recorded on a Bruker BioSpin 500 MHz/400 MHz spectrometer (Bruker, Germany). ^1^H NMR provides information related to the molecular structure and the stoichiometry in the crystal lattice. ^1^H NMR was recorded in a DMSO-*d*~6~ solvent with tetramethylsilane as the internal reference standard (δ = 0). For the analysis, approximately 5--10 mg of the samples was dissolved in a DMSO-*d*~6~ solvent and the spectra were recorded with 16 numbers of scans. MestReNova 7.0.0.8331 software was used to process the raw NMR data.

Powder X-ray Diffraction {#sec4-5}
------------------------

PXRD was recorded on a JEOL JDX-8 PXRD instrument in the scan range of 2θ = 5°--50°. For a typical experiment, samples were placed on the standard sample holder and then scanned continuously at a scan rate of 2° min^--1^.

Infrared Spectroscopy {#sec4-6}
---------------------

FT-IR spectra were recorded on a Nicolet Avatar 330 instrument in the scan range of 400--4000 cm^--1^. In a typical experiment, approximately 10--15 mg of the samples was mixed with KBr, ground well using a mortar, and pressed with a steel die into a pellet. The FT-IR spectra were collected for 16 scans at a resolution of 4 cm^--1^.

Differential Scanning Calorimetry {#sec4-7}
---------------------------------

DSC analysis was performed on a DSC 60 differential scanning calorimeter (Shimadzu, Japan) which was calibrated for temperature and enthalpy using a Tin standard material. For the analysis, 2--5 mg of the samples was placed into an aluminum pan, and it was covered with a crimped lid. This weighed, crimped aluminum pan was kept in the sample reference cell and scanned from 30 to 350 °C at a heating rate of 10 °C/min under a continuously purged dry nitrogen atmosphere.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.7b00878](http://pubs.acs.org/doi/abs/10.1021/acsomega.7b00878).DSC plot and PXRD comparison plots; comparison of FT-IR spectra of the molecular salts with those of their starting materials, ^1^H NMR spectra of the molecular salts; isostructurality comparison; torsion angles; list of FT-IR stretching frequencies; and ^1^H NMR chemical shifts ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00878/suppl_file/ao7b00878_si_001.pdf))Crystallographic data of the molecular salts of 2c4n ([CIF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.7b00878/suppl_file/ao7b00878_si_002.cif))
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